Year-End Termination

NOVARTIS VACCINES AND DIAGNOSTICS, INC. for NOVARTIS VACCINES AND DIAGNOSTICS INC

Firm
Client
Income
—
Expenses
$280,000

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

HR 4703, To amend the Social Security Act, the Federal Food Drug and Cosmetic Act, and the Public Health Serice Act to ensure a sufficient supply of vaccines and for other purposes, influenza issues HR 4704, To amend title XVIII of the Social Security Act to provide for coverage of federally recommended vaccines under Medicare part B, vaccine reimbursement issues HR 4705, to amend the Public Health Service Act to increase availability of vaccines, and for other purposes, addressed influenza vaccine issues

LobbyistCovered position, as disclosed
MARGUERITE BAXTER N/A

Contacted: HOUSE OF REPRESENTATIVES; UNDETERMINED; Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 4705 (110th), H.R. 4703 (110th), H.R. 4704 (110th)

Budget/Appropriations BUD

S. 1710, Labor-HHS-Education and related Agencies Appropriations Act, pandemic funding and vaccine issues HR 3043, Labor - HHS-Education and related Agencies appropriations Act, pandemic influenza funding and vaccine issues HJ Res. 20, revised Continuing Appropriations Resolution, pandemic influenza fundingHR 2764/PL 110-16, Consolidated Appropriations Act, 20008

LobbyistCovered position, as disclosed
MARGUERITE BAXTER N/A

Contacted: UNDETERMINED; SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.J.Res. 20 (110th), H.R. 3043 (110th), S. 1710 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.